[Elsevier] Atrasentan in patients with IgA nephropathy (ALIGN): final 2﹞5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial |
|
This post will be closed automatically in 2026-11-12 21:57
Best Answer
19 min. ago
|
| |
post
reply
points
169455
70
Plasticity of parylene memristors: Compact phenomenological model and synaptic properties
30
Changes of proximal caries during orthodontic treatment using intraoral scans with near-infrared imaging
10
Piezo-modulated interface field facilitating hydroxyl radical formation of SrTiO3/ZnO heterojunction for water purification
30
Continuous vs intermittent meropenem administration in critically ill patients and renal function. A secondary post-hoc analysis of the MERCY trial
10
Structural, magnetic and adsorptive properties of nano spinel of cobalt aluminate doped with nickel for Cr(VI) removal
Daily Aid:349
Daily Aid:262
Daily Aid:61
Daily Aid:59
Daily Aid:46
Daily Aid:41
Daily Aid:39
